Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome.
about
Reference point insensitive molecular data analysis.Adjusting microbiome profiles for differences in microbial load by spike-in bacteriaRole of the intestinal mucosa in acute gastrointestinal GVHD.Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.Probiotic lactic acid bacteria - the fledgling cuckoos of the gut?Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiotaIncreased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.Pathophysiology of GvHD and Other HSCT-Related Major Complications.Indoles from commensal bacteria extend healthspan.Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.Gut microbiota and hematopoietic stem cell transplantation: where do we stand?Intestinal microbiome changes and stem cell transplantation: Lessons learned.The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.Clinical Evidence for the Microbiome in Inflammatory Diseases.Microbial metabolites and graft versus host disease.Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation.Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations?Role of gut flora after bone marrow transplantation.The Stool Microbiota at Neutrophil Recovery is Predictive for Severe Acute Graft versus Host Disease after Hematopoietic Cell Transplantation.The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation.Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome.Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients.Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation.Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.Biomarkers for post-transplantation outcomes.Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.Urinary Virome Perturbations in Kidney Transplantation.Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityTreating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study
P2860
Q31131120-7A57B9F9-4EFC-46C9-931D-632B9CC04D29Q36058220-9BC09E15-1502-4146-8061-D85DCF99134CQ36212428-8D590471-2FB1-45FF-A5B7-7380DB104BD9Q36289007-E2E95F4F-F92B-45DD-B5D5-F3C3D7FA89CAQ36945060-2421496E-E838-4753-8B14-AC824B13032EQ37079102-1BDF7F53-97B1-4CF3-BCB5-34609CF7BDC1Q37191056-B4B0B93A-F458-4A29-9482-067A0E0ED7E3Q37376599-D6FB1294-7E02-4C73-8BC0-A5A5EB6B207BQ37486151-E8ACDF67-897F-478A-8495-E2A875CF095FQ37587724-3F1A4692-D5E7-41EB-948A-25354AF20971Q37672390-9E740044-89C2-4F50-A154-4649B7E64D77Q37710572-07ECF9A8-507D-4D45-A5B1-4DBB6841DB3DQ38615476-7C8F1759-41A2-44A2-8A3C-CCB2C0DE6702Q38743931-D21A32D0-7A5F-44B8-9D63-17B9886D9D4CQ38878477-7BB64766-0DE0-40AD-BE5F-54A3391C0F4EQ38996681-68A75A70-AABA-4295-A99A-EE08AB598DA7Q39035437-060B92CB-C9CE-4324-A779-36C93A3889C7Q39265428-EB73D9C4-B92F-4E2B-9767-5F3790DD2717Q39457656-3DAADAF6-FFCC-48DD-9E8A-F6132168D03FQ39901709-2E4D3B90-F172-4D17-BBC5-ABAAC9003904Q40112657-ADF2E5E1-F9B3-4FC0-AACC-D89BC1815905Q40129363-0C4EF8BA-EA7A-426B-9357-778C0A30CA66Q40749194-CF4ED87F-B3F5-4B23-BE76-B9642E72A748Q41115262-A8F0C112-EFDC-483A-927C-899933895E52Q41987235-3EBC3072-4591-40B7-A4D5-AD3C011C2A2EQ42053800-8D351666-8C94-4320-B84F-D3243ADB05EDQ42367849-52E4ADAB-586A-4F77-9DD9-5BFA88FB6B01Q45875683-1326299A-55F8-42AB-933F-5876FD4142BBQ46236950-AA977D81-6588-4CD6-BC18-25588793996BQ47608782-0A7D4F74-D8D3-4979-B2FC-AC2A4AE2C03FQ48260491-ED04A977-0ABC-4EBE-B76A-9F9F6FF279F8Q52603913-6741A3F4-6CBB-4482-AF07-6852CA0F4BE8Q52677571-C72058BF-A3E1-4856-8646-FBE5898E620DQ52689883-390D0F03-12F3-428E-B9E7-E2B1CFB2E822Q54000190-C8D825F3-5A30-4409-B5AF-7B13D6D60783Q54978699-87040BBA-4DFC-4935-A7B6-E84758362F87Q56379522-A3435082-6725-42F4-9767-E8D75B676102Q57492011-8F8B6E45-C2E9-48B4-9B28-5472E2FC3DAC
P2860
Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Low urinary indoxyl sulfate le ...... associated with poor outcome.
@ast
Low urinary indoxyl sulfate le ...... associated with poor outcome.
@en
type
label
Low urinary indoxyl sulfate le ...... associated with poor outcome.
@ast
Low urinary indoxyl sulfate le ...... associated with poor outcome.
@en
prefLabel
Low urinary indoxyl sulfate le ...... associated with poor outcome.
@ast
Low urinary indoxyl sulfate le ...... associated with poor outcome.
@en
P2093
P1433
P1476
Low urinary indoxyl sulfate le ...... e associated with poor outcome
@en
P2093
André Gessner
Daniel Wolff
Daniela Weber
Ernst Holler
Joachim Hahn
Josef Koestler
Katja Dettmer
Markus Weber
Peter J Oefner
Rainer Spang
P304
P356
10.1182/BLOOD-2015-04-638858
P407
P577
2015-07-24T00:00:00Z